Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulinastatin dose response in ARDS
NCT02895191Phase 2Unknown
- Sponsor
- Guangdong Techpool Bio-pharma
- Start
- Aug 2016
- Primary completion
- Sep 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of ulinastatin in acute respiratory distress syndrome (ARDS), sponsored by Guangdong Techpool Bio-pharma. Status: unknown.
02
Drugs
ulinastatin
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT02895191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02895191.